Logo

OGT

Oxford Gene Technology Expands NGS Offering Into Constitutional Cytogenetics
Premium

The company believes cytogeneticists will adopt its panel to get high-quality SNV and CNV data in a single assay.

Sysmex to Acquire Oxford Gene Technology

The acquisition allows Sysmex to enter the cytogenetics market and strengthens its technology base in molecular genetics, while expanding its life science business. 

Oxford Gene Technology Bets on Design, Flexibility to Woo Clinical Labs With New NGS Cancer Panel
Premium

The British molecular genetics company recently announced a menu update for its SureSeq myPanel NGS Custom Cancer Panel offering.

Oxford Gene Technology FY16 Revenues Up 15 Percent

The revenue growth comes amid increased demand for the company's molecular genetics products.

In Brexit Britain, Genomics Community Anxious About Future EU Funding, Collaboration, Innovation
Premium

Interviews with leading UK scientists revealed apprehension about losing access to European funding, limitations on freedom of movement, and an exodus of biotechs to the EU.

Oct 6, 2015

OGT FISH Kit for Bladder Cancer Gets CE-IVD Mark

Sep 10, 2015

Sengenics Buys Oxford Gene Technology's Protein Array Platform

Sep 3, 2015

OGT Transfers NGS Services to Source BioScience, Will Focus on Genomic Products

Aug 10, 2015

OGT Focuses on Small NGS Cancer Panels for Clinical Research; Will Launch CE-IVD NIPT Array
Premium

Apr 8, 2015

OGT Aims for May Launch of Next-gen Cytogenic Arrays
Premium

Feb 3, 2015

For PGS Market Entry, Agilent Draws on Dubai IVF Clinic Partnership, New 16-Plex Array Format
Premium

Jan 20, 2015

Reproductive Health Science Scales up Array Manufacturing to Support EmbryoCellect Test
Premium

Dec 2, 2014

OGT's FY2014 Revenues Rise 27 Percent on CytoSure Array, Cytocell FISH Sales, NGS Services
Premium

Oct 28, 2014

OGT to Commence Clinical Trial for New Array-based Non-invasive Prenatal Test for Down's Syndrome
Premium

Oct 14, 2014

OGT Sees New Medical Research Exome Array as 'Perfect Complement' to Next-gen Sequencing Workflows
Premium

Aug 1, 2014

OGT Receives $300K SBRI Grant to Work on New Variant Interpretation Software Product
Premium

Jul 15, 2014

OGT Expands Pre-implantation Genetic Screening Offering with New Embryo Screen Array
Premium

May 12, 2014

UK Department of Health Announces SBRI Genomics Grant Winners

Apr 1, 2014

OGT Positions New CytoSure Medical Exome Array as Complement to Sequencing-based Tests
Premium

Mar 28, 2014

Downloads and Upgrades: Sequencher 5.2, Syapse, CytoSure Interpret 4.5.3, and more
Premium

Mar 25, 2014

New Products: OGT's CytoSure Interpret Software
Premium

Mar 11, 2014

OGT, Emory Genetics Lab Collaborate on New CGH Arrays

Mar 11, 2014

New Products: OGT's CytoSure Molecular Arrays, Golden Helix's SNP & Variation Suite 8
Premium

Mar 4, 2014

OGT Complements Chromosomal Microarray Portfolio with Acquisition of FISH Probe Firm Cytocell
Premium

Mar 4, 2014

OGT Acquires UK FISH Probe Maker Cytocell

Breaking News
The Scan

Transplant Tests Edited Pig Kidneys

The Associated Press reports a University of Alabama-Birmingham team transplanted genetically modified pig kidneys into a brain-dead human patient.

UK Changes Some Gene-Edited Crop Rules

A new law may enable gene-edited crops to be sold in the UK within about five years, New Scientist says.

Pill Works Against Omicron in Lab

Pfizer's antiviral pill to treat SARS-CoV-2 appears to work against the Omicron variant, the Wall Street Journal reports.

Nature Papers Find Genetic Risk Factor for Smell, Taste Loss in COVID-19; Analyze TB Granulomas

In Nature this week: genome-wide association study find locus linked to the risk COVID-19 patients losing their sense of taste or smell, and more.